About Zika Virus Envelope (E) Glycoprotein

Zika virus (ZIKV) is a mosquito-borne flavivirus associated with congenital Zika syndrome, neurological complications, and epidemic outbreaks worldwide. The Envelope (E) glycoprotein is the major surface protein of Zika virus and plays a critical role in viral attachment, receptor binding, membrane fusion, and host-cell entry. As the principal antigen exposed on the virion surface, the E protein is the primary target of neutralizing antibodies generated during natural infection and vaccination. Because of its essential role in viral infectivity and immune recognition, the Zika virus E protein has become a key target for vaccine development, antibody discovery, diagnostic assay development, and antiviral research.

eEnzyme's recombinant Zika Virus Envelope (E) Glycoprotein provides a valuable research tool for the study of viral pathogenesis, immune responses, vaccine development, and therapeutic antibody discovery. The protein is suitable for antibody screening, vaccine evaluation, receptor-binding studies, structural biology investigations, epitope mapping, and immunological assay development. Researchers can utilize this recombinant antigen to investigate mechanisms of viral entry, characterize neutralizing antibody responses, and support the development of next-generation vaccines and therapeutics against Zika virus infection.

Applications of Zika Virus Envelope Glycoprotein E

• Neutralizing antibody discovery and characterization
• Zika virus vaccine development and evaluation
• Viral attachment and entry studies
• Receptor-binding investigations
• Structural biology and epitope mapping
• ELISA, Western blot, and immunological assays

Biological Significance of the E Protein

The Zika virus Envelope protein functions as the primary mediator of viral entry into host cells. Following receptor attachment, the E protein undergoes conformational changes that facilitate fusion between the viral envelope and host-cell membranes, enabling delivery of the viral genome into the host cell. Because the E protein contains the major neutralizing epitopes recognized by protective antibodies, it remains the most important antigen for vaccine development, therapeutic antibody discovery, and diagnostic assay design. Studies of flavivirus immunity consistently demonstrate that the E protein is a dominant target of humoral immune responses and a critical determinant of protective immunity against infection.

Selected References:

1) Henderson, E. A. et al. Investigation of the immunogenicity of Zika glycan loop. Virol. J. 17, 1–15 (2020)  
2) Henderson, E. Development of Novel Zika and Anthrax Viral Nanoparticle Vaccines. Scholarsh. @ Claremont (2019).